Cargando…
Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties
BACKGROUND: Cilastatin (CL) is an inhibitor of dehydropeptidase-I, which is safely used in clinical practice to prevent nephrotoxicity of antibiotics. Tacrolimus (TAC) is the most important immunosuppressant in renal transplantation, but it causes considerable nephrotoxicity. We evaluated the protec...
Autores principales: | Luo, Kang, Lim, Sun Woo, Jin, Jian, Jin, Long, Gil, Hyo Wook, Im, Dai Sig, Hwang, Hyeon Seok, Yang, Chul Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570925/ https://www.ncbi.nlm.nih.gov/pubmed/31200653 http://dx.doi.org/10.1186/s12882-019-1399-6 |
Ejemplares similares
-
Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity
por: Humanes, Blanca, et al.
Publicado: (2015) -
Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy
por: Kim, Jin Won, et al.
Publicado: (2021) -
Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation
por: Hong, Yu Ah, et al.
Publicado: (2020) -
Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy
por: Zaballos, Matilde, et al.
Publicado: (2021) -
Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)
por: Huo, Xiaokui, et al.
Publicado: (2019)